The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design
Open Access
- 9 May 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (5) , e0197115
Abstract
The polymorphisms at the α-chain of the IL-7 receptor (IL7RA) have been related to T-cell homeostasis and development and may contribute to immune system deregulation. In the present study, we analyzed the association between IL7RA polymorphisms and the progression of liver fibrosis in patients infected with HCV. We carried out a retrospective study with a design consisting of repeated measurements in 187 HCV-infected patients, to study the risk prediction of liver fibrosis progression using genetic factors. We genotyped the rs6897932, rs987106 and rs3194051 IL7RA polymorphisms using the Agena Bioscience’s MassARRAY. Transient elastography was used to measure liver stiffness. The used cut-offs were: 0.05). In univariate analysis, the rs6897932 T allele had a positive relationship with an increase in LSM (arithmetic mean ratio (AMR) = 1.21 (95%CI = 1.08; 1.36); p = 0.001), progression to advanced fibrosis (F≥3) (odds ratio (OR) = 2.51 (95%CI = 1.29; 4.88); p = 0.006) and progression to cirrhosis (F4) (OR = 2.71 (95%CI = 0.94; 5.03); p = 0.069). In multivariable analysis, the rs6897932 T allele was related to a higher increase of LSM values during follow-up (adjusted AMR = 1.27 (95%CI = 1.13; 1.42); pIL7RA rs987106 and rs3194051 polymorphisms, we did not find significant results except for the relationship between IL7RA rs987106 and the increase in LSM values [adjusted OR = 1.12 (95%CI = 1.02; 1.23); p = 0.015]. The IL7RA rs6897932 polymorphism seems to be related to increased risk of liver fibrosis progression in HCV-infected patients. Thus, the rs6897932 polymorphism could be related to the physiopathology of CHC and might be used to successfully stratify the risk of CHC progression.Keywords
Funding Information
- Instituto de Salud Carlos III (PI14CIII/00011)
- Instituto de Salud Carlos III (PI15CIII/00024)
- Instituto de Salud Carlos III (CP14/0010)
- Instituto de Salud Carlos III (PT13/0001)
This publication has 48 references indexed in Scilit:
- Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunityProceedings of the National Academy of Sciences, 2013
- Chronic hepatitis C virus (HCV) disease burden and cost in the United StatesHepatology, 2012
- The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cARTGenes & Immunity, 2011
- IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ PathologyCell, 2011
- Biological Determinants of Immune Reconstitution in HIV‐Infected Patients Receiving Antiretroviral Therapy: The Role of Interleukin 7 and Interleukin 7 Receptor α and Microbial TranslocationThe Journal of Infectious Diseases, 2010
- Soluble IL-7Rα (sCD127) Inhibits IL-7 Activity and Is Increased in HIV InfectionThe Journal of Immunology, 2010
- Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor alpha gene influences the frequency of recent thymic emigrantsGenes & Immunity, 2010
- Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosisNature Genetics, 2007
- Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective studyGut, 2006
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005